Literature DB >> 16428316

Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy.

Upal K Basuroy1, Eugene W Gerner.   

Abstract

The polyamines are important molecules governing cell proliferation, survival and apoptosis. Consistent with their elevated levels in cancer, they have been shown to mediate tumor promotion and progression. Cellular and tissue polyamine pools and metabolic flux are regulated by a number of processes. Neoplastic transformation is accompanied with an increase in biosynthesis, decreased catabolism and elevated uptake of exogenous polyamines. Effective strategies for cancer chemoprevention and chemotherapy, targeting the polyamine metabolic pathway will likely require a combination of agents acting at multiple sites of this pathway. Genetic variability affecting expression of the ornithine decarboxylase gene suggests an association between ODC expression and cancer risk, and prediction of response to treatment in certain epithelial cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428316     DOI: 10.1093/jb/mvj022

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  27 in total

Review 1.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Dietary polyamine intake and risk of colorectal adenomatous polyps.

Authors:  Ashley J Vargas; Betsy C Wertheim; Eugene W Gerner; Cynthia A Thomson; Cheryl L Rock; Patricia A Thompson
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

3.  Circadian variations in rat liver gene expression: relationships to drug actions.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Debra C DuBois; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2008-06-18       Impact factor: 4.030

4.  Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.

Authors:  Ying Xie; Tracy Murray-Stewart; Yazhe Wang; Fei Yu; Jing Li; Laurence J Marton; Robert A Casero; David Oupický
Journal:  J Control Release       Date:  2016-12-23       Impact factor: 9.776

5.  Characterization of transgenic mice with overexpression of spermidine synthase.

Authors:  Chenxu Shi; Patricia A Welsh; Suzanne Sass-Kuhn; Xiaojing Wang; Diane E McCloskey; Anthony E Pegg; David J Feith
Journal:  Amino Acids       Date:  2011-08-02       Impact factor: 3.520

Review 6.  Structural biology of S-adenosylmethionine decarboxylase.

Authors:  Shridhar Bale; Steven E Ealick
Journal:  Amino Acids       Date:  2009-12-08       Impact factor: 3.520

7.  S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Authors:  Chenxu Shi; Timothy K Cooper; Diane E McCloskey; Adam B Glick; Lisa M Shantz; David J Feith
Journal:  Carcinogenesis       Date:  2012-05-19       Impact factor: 4.944

Review 8.  Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.

Authors:  Nicholas F Evageliou; Michael D Hogarty
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

9.  Identification of a new endogenous metabolite and the characterization of its protein interactions through an immobilization approach.

Authors:  Jarosław Kalisiak; Sunia A Trauger; Ewa Kalisiak; Hirotoshi Morita; Valery V Fokin; Mike W W Adams; K Barry Sharpless; Gary Siuzdak
Journal:  J Am Chem Soc       Date:  2009-01-14       Impact factor: 15.419

10.  ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

Authors:  Michael D Hogarty; Murray D Norris; Kimberly Davis; Xueyuan Liu; Nicholas F Evageliou; Candace S Hayes; Bruce Pawel; Rong Guo; Huaqing Zhao; Eric Sekyere; Joanna Keating; Wayne Thomas; Ngan Ching Cheng; Jayne Murray; Janice Smith; Rosemary Sutton; Nicola Venn; Wendy B London; Allen Buxton; Susan K Gilmour; Glenn M Marshall; Michelle Haber
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.